NewAmsterdam Pharma Management
Management criteria checks 2/4
NewAmsterdam Pharma's CEO is Michael Davidson, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is $5.81M, comprised of 9.8% salary and 90.2% bonuses, including company stock and options. directly owns 0.89% of the company’s shares, worth $20.44M. The average tenure of the management team and the board of directors is 2.1 years and 2 years respectively.
Key information
Michael Davidson
Chief executive officer
US$5.8m
Total compensation
| CEO salary percentage | 9.8% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.9% |
| Management average tenure | 2.1yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$199m |
| Jun 30 2024 | n/a | n/a | -US$229m |
| Mar 31 2024 | n/a | n/a | -US$229m |
| Dec 31 2023 | US$6m | US$569k | -US$177m |
Compensation vs Market: Michael's total compensation ($USD5.81M) is about average for companies of similar size in the US market ($USD5.36M).
Compensation vs Earnings: Insufficient data to compare Michael's compensation with company performance.
CEO
Michael Davidson (68 yo)
4.3yrs
Tenure
US$5,809,158
Compensation
Dr. Michael Harvey Davidson, M.D., FACC., FNLA, serves as Director at Nanophoria S.R.L. since January 2024. Dr. Davidson is a Co-Founder and Chief Scientific Officer of TROFI NUTRITIONALS, INC. He serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 4.3yrs | US$5.81m | 0.89% $ 20.4m | |
| Founder | 5.8yrs | US$2.98m | 0.25% $ 5.7m | |
| Chief Financial Officer | 1.1yrs | US$3.82m | no data | |
| Chief Business Officer | less than a year | US$45.63k | 0.0012% $ 27.5k | |
| Chief Operating Officer | 3.7yrs | no data | 0% $ 0 | |
| Chief Accounting Officer | 1.1yrs | no data | 0% $ 0 | |
| Executive VP &Head of Investor Relations | 1.6yrs | no data | no data | |
| Chief Legal Officer & Secretary | 2yrs | no data | no data | |
| Executive Vice President of Marketing | 1.8yrs | no data | no data | |
| Chief Development Officer | 2.3yrs | no data | 0% $ 0 | |
| Chief Manufacturing Officer | 3.6yrs | no data | no data | |
| Executive VP & Head of Global Regulatory Affairs | 3.7yrs | no data | no data |
2.1yrs
Average Tenure
51yo
Average Age
Experienced Management: NAMS's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 2yrs | US$5.81m | 0.89% $ 20.4m | |
| Founder | 2yrs | US$2.98m | 0.25% $ 5.7m | |
| Independent Non-Executive Director | 2yrs | US$339.05k | 0.027% $ 621.2k | |
| Non-Executive Director | 2yrs | US$40.00k | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Chairman of Board of Directors | less than a year | no data | no data | |
| Independent Director | 1.8yrs | US$138.83k | 0% $ 0 | |
| Non-Executive Director | less than a year | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
2.0yrs
Average Tenure
68yo
Average Age
Experienced Board: NAMS's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.